Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Apr 3;7:546. doi: 10.1038/s41598-017-00431-1

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2017

This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

PMC Copyright notice

IL-10 expression in B cells and its correlation with miR-19a. (A,B) (20 patients/group), peripheral B cells of AR patients were prepared before the therapy (0 month) and 6 month after the start of the therapy (as denoted on the X axis); the B cells were analyzed by RT-qPCR and Western blotting. (A) The bars indicate the IL-10 mRNA in B cells (mean ± SD). (B) The immune blots indicate the protein levels of IL-10. (C) The curves indicate the individual data of miR-19a levels and IL-10 mRNA levels in the B cells of 10 randomly selected AR patients. *p < 0.01, compared to the placebo group. ^#p < 0.01, compared with the SIT/VD3 group. The full-length gels and blots are included in the supplementary information.